Minnetronix Medical and INO Announce Strategic Partnership that Fast Tracks Optical Medical Device Development & Commercialization

Cutting-Edge Applied Research and Technology Save Time and Money throughout the Product Lifecycle

Minnetronix Medical, a U.S.-based medical device technology partner offering full lifecycle design and manufacturing services, and INO Innovation Center, Canada’s largest and most advanced center of applied research and expertise in optics and photonics, have announced a strategic partnership to innovate and accelerate bringing optical medical devices to market.

Working with the Minnetronix-INO team, medical device companies gain access to deep expertise in optics and photonics and a seamless solution for bringing highly integrated optical medical devices from concept through commercial production.

Minnetronix’ suite of services is unique in the medical device industry because it includes full lifecycle support across medical device design, development, supply chain, and manufacturing. INO is a global leader in the optics field with the ability to control light to capture, identify, predict, and transform data into valuable and actionable information through multiple light applications — from laser and fiber optic technologies to imaging systems.

“There is increased complexity in creating optical medical devices, which this partnership solves,” said Matt Adams, vice president and general manager at Minnetronix. “For example, the supply chain for complex medical optics is often fragmented requiring customers to find specialized expertise in multiple small firms. Now, customers get the best brains in the industry under one umbrella to get their products to market faster.” Adams adds that combining this joint expertise with a simple onboarding and project management process allows customers to seamlessly engage the team as a “one-stop shop” for optic and photonic projects.

“With more than 50 years of leading expertise in optics between INO and Minnetronix, our combined strengths will play a significant role in advancing our customers’ optics-based medical devices to the market.” said Louis Martel, Vice President Business Development and Partnership at INO.

The new partnership expands Minnetronix’ optics business and INO’s reach into the U.S. INO has implemented more than 6,500 solutions, carried out 75 technology transfers, and contributed to the creation of 35 new companies.

The new collaboration has already completed its first successful project: INO developed a smart illumination system when no other commercial solutions were available, while Minnetronix led the complex system integration, including the proprietary illumination system, to deliver the final product to the customer.

The partnership can also manage projects that require optical subsystems within larger, complex medical device systems; have complicated or diverse supply chains and/or require regulatory insights to scope design considerations relative to the FDA pathway.

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."